Cargando…
Comprehensive Genetic Testing for Pediatric Hypertrophic Cardiomyopathy Reveals Clinical Management Opportunities and Syndromic Conditions
Hypertrophic cardiomyopathy (HCM) has historically been diagnosed phenotypically. Through genetic testing, identification of a molecular diagnosis (MolDx) is increasingly common but the impact on pediatric patients is unknown. This was a retrospective study of next-generation sequencing data for 602...
Autores principales: | Gal, Dana B., Morales, Ana, Rojahn, Susan, Callis, Tom, Garcia, John, Priest, James R., Truty, Rebecca, Vatta, Matteo, Nussbaum, Robert L., Esplin, Edward D., Hollander, Seth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554517/ https://www.ncbi.nlm.nih.gov/pubmed/34714385 http://dx.doi.org/10.1007/s00246-021-02764-1 |
Ejemplares similares
-
Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis
por: Sturm, Amy C., et al.
Publicado: (2021) -
Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing
por: Dellefave-Castillo, Lisa M., et al.
Publicado: (2022) -
Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
por: Östman-Smith, Ingegerd
Publicado: (2014) -
Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
por: Hussain, Tarique, et al.
Publicado: (2013) -
Pediatric Hypertrophic Cardiomyopathy: Exploring the Genotype‐Phenotype Association
por: Nguyen, Minh B., et al.
Publicado: (2022)